MH

Michael Hayden

UC University Of British Columbia: 13 patents #29 of 1,308Top 3%
PN Prilenia Neurotherapeutics: 10 patents #1 of 28Top 4%
XP Xenon Pharmaceuticals: 6 patents #34 of 146Top 25%
SC Staging Concepts: 5 patents #1 of 5Top 20%
WARF: 4 patents #486 of 4,123Top 15%
UN Unknown: 3 patents #7,366 of 83,584Top 9%
University Of Texas System: 2 patents #1,567 of 6,559Top 25%
AR Agency For Science, Technology And Research: 1 patents #909 of 2,337Top 40%
TI Teva Pharmaceutical Industries: 1 patents #294 of 489Top 65%
HD Hadasit Medical Research Services And Development: 1 patents #139 of 373Top 40%
IP Isis Pharmaceuticals: 1 patents #254 of 400Top 65%
AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
NS National University Of Singapore: 1 patents #498 of 1,623Top 35%
HP Hsc Research And Development Limited Partnership: 1 patents #40 of 109Top 40%
Overall (All Time): #84,942 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 26–38 of 38 patents

Patent #TitleCo-InventorsDate
7696151 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents Alison J. Brownlie, James M. Ntambi, Makoto Miyazaki, Mark Gray-Keller, Alan Attie 2010-04-13
7624540 Stage system with connectable corner Danny D. Scott 2009-12-01
7166584 Cholesterol transport gene Alan Attie, Mark E. Cook, Mark Gray-Keller, Simon Pimstone, Angela Brooks-Wilson 2007-01-23
6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents Alison J. Brownlie, James M. Ntambi, Makoto Miyazaki, Mark Gray-Keller, Alan Attie 2006-01-17
6814962 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same Patrick Benoit, Patrice Denefle, Michel Perricaudet, M. E. Suzanne Lewis 2004-11-09
6784162 Gene therapy method for reducing risk of atherosclerosis Yuanhong MA, Suzanne Lewis, Guoquing Liu 2004-08-31
6617122 Process for identifying modulators of ABC1 activity Angela R. Brooks-Wiison, Simon Pimstone 2003-09-09
6235879 Apoptosis modulators that interact with the Huntington's disease gene Michael Kalchman, Abigail Hackam, Vikramjit S. Chopra, Paul Goldberg 2001-05-22
5938364 Staging support 1999-08-17
5935675 Stage system Glynn Neumann 1999-08-10
5849995 Mouse model for Huntington's Disease and related DNA sequences Biaoyang Lin, Jamal Nasir 1998-12-15
5658729 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis Yuanhong MA, Suzanne Lewis, Guoquing Liu 1997-08-19
5534438 Process for isolating genes and the gene causative of Huntington's disease and differential 3' polyadenylation in the gene Paul Goldberg, Susan Andrew, Johanna M. Rommens 1996-07-09